Asthma trials in United Kingdom

In United Kingdom 48 Also abroad 500

48 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Chronic Respiratory Disease Participant Engagement Study
Where
London
Age
18 years and over
People
500
Run by
Richmond Research Institute
See details and how to joinNCT07924462
Phase 1Taking people
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Where
Manchester
Age
18 years to 65 years
People
84 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06433921 · EU 2024-511220-14-00
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Bradford, Cambridge, Crumpsall, London, Manchester, Wakefield
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 3Taking people
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Where
Oxford
Age
18 years to 79 years
People
150 worldwide
Run by
Université de Sherbrooke
See details and how to joinNCT07309614
Phase 3Taking people
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Where
Great Cambourne, Greater Manchester
Age
18 years and over
People
110 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07645248
No phaseTaking people
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
Where
Cambridge
Age
18 years to 60 years
People
36
Run by
Akhilesh Jha
See details and how to joinNCT06488118
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Where
Ashburton, Bristol, High Wycombe, Honiton, London, Metropolitan Borough of Wirral, Nottingham, Plymouth, Romford, Rotherham, Sheffield, Somerton, Thetford
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07359846
No phaseTaking people
Remote Monitoring of Asthma in Children and Young People
Where
Edinburgh
Age
5 years to 17 years
People
900
Run by
University of Edinburgh
See details and how to joinNCT07129616
Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
London
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
No phaseTaking people
A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD
Where
Liverpool
Age
18 years to 110 years
People
1,200
Run by
Liverpool Heart and Chest Hospital NHS Foundation Trust
See details and how to joinNCT07253883
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Birmingham, Bradford, Bristol, Glasgow, Leicester, London, Nottingham, Stoke-on-Trent
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 1Taking people
Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma
Where
Leeds, London, Manchester
Age
18 years to 65 years
People
120
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07851623
No phaseEnrolling by invitation
Co-morbidity and Refractory Asthma - UK Severe Asthma Registry
Where
Belfast
Age
16 years and over
People
4,800
Run by
Queen's University, Belfast
See details and how to joinNCT04553276
No phaseTaking people
Study of Hospitalised Patients With Acute Respiratory Conditions
Where
Leicester
Age
18 years to 90 years
People
500
Run by
University of Leicester
See details and how to joinNCT05095090
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Bedford, Birmingham, Bristol, Leicester, London, Wythenshawe
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
No phaseNot yet taking people in United Kingdom
Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
Where
Leicester
Age
18 years and over
People
80
Run by
University of Leicester
See details and how to joinNCT07500948
No phaseTaking people
N-WATCH: Nottingham Wheeze Assessment in Tidal Children
Where
Nottingham
Age
5 years to 15 years
People
340
Run by
University of Nottingham
See details and how to joinNCT07833826
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Bradford, Cambridge, Chertsey, Glasgow, London
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseTaking people
A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma
Where
Portsmouth
Age
18 years and over
People
2,000
Run by
Portsmouth Hospitals NHS Trust
See details and how to joinNCT06286085
No phaseTaking people
A Randomised Feasibility Study of CPAP in Large Airway Collapse
Where
Liverpool
Age
18 years and over
People
60
Run by
Liverpool School of Tropical Medicine
See details and how to joinNCT07504926
Phase 1/2Taking people
RIG 101 Trial in Healthy Adults and Adults With Asthma
Where
London, Manchester
Age
18 years to 65 years
People
82
Run by
RIGImmune Inc.
See details and how to joinNCT07488897
Phase 2Taking people
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Where
London, Stoke-on-Trent
Age
6 years to 11 years
People
42 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05222529 · EU 2024-511382-11-00
Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Bradford
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
No phaseTaking people
Physical Activity Promotion and Clinical Remission in Severe Asthma
Where
Leeds
Age
18 years to 70 years
People
140
Run by
University of Leeds
See details and how to joinNCT07735494
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Birmingham, Bradford, Leicester, London
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00